Abbott ADC-75852 Libre View Healthcare Professionals User Guide

User Guide for Abbott models including: ADC-75852 Libre View Healthcare Professionals, ADC-75852, Libre View Healthcare Professionals, View Healthcare Professionals, Healthcare Professionals, Professionals

LibreView* Quick Reference Guide

LibreView Quick Reference Guide

*Default range is 70-180 mg/dL. The LibreView data management software is intended for use by both patients and healthcare professionals to assist people with diabetes and their healthcare professionals in the review, analysis

File Info : application/pdf, 6 Pages, 884.28KB

ADC-75852 LibreView Quick Reference Guide

LibreView* Quick Reference Guide

Save time by using LibreView*
· Access real-time patient data anytime, anywhere · View easy-to-understand reports1 · Make more informed treatment decisions1

LibreView

Abbott thefullest

Not actual patient data; for illustrative purposes only.

*The LibreView data management software is intended for use by both patients and healthcare professionals to assist people with diabetes and their healthcare professionals in the review, analysis and evaluation of historical glucose meter data to support effective diabetes management. The LibreView software is not intended to provide treatment decisions or to be used as a substitute for professional healthcare advice. The user's device must have internet connectivity for glucose data to automatically upload to LibreView. Glucose readings are not available during 1-hour warm-up, when sensor is too hot or too cold, when you see an error or "LO" or "HI" message, or no current glucose reading.

1. Unger, Jeff, Pamela Kushner, and John E. Anderson. "Practical Guidance for Using the FreeStyle Libre Flash Continuous Glucose Monitoring in Primary Care." Postgraduate Medicine 132, no. 4 (May 2020): 305-313. https://doi.org/10.1080/00325481.2020.1744393.

See last page for Important Safety Information.

Incorporating LibreView* into your practice

Follow these steps to get the most out of LibreView*

1
Select a LibreView* report: · Compare patient glucose data and time in ranges
with American Diabetes Association (ADA) recommendations (A1c <7% or TIR >70%, with time below range <4%, for most adults)1
3
Discuss with the patient2: · What are possible causes of hypoglycemic events? · Where can improvements be made? · How can we replicate what is working well?
5
Set or reassess individual goals2: · Discuss physical activity, diet, and medication
changes4

2
Assess patient safety by identifying2: · Any hypoglycemic events or patterns · Postprandial spikes in glucose · Periods of high glycemic variability
4
Identify and celebrate positive modifications2: · Amount of time CGM is active (recommend
70% time active3) · Periods of sustained time in range · Days without severe highs or lows

7
Document the visit5:
· Current procedural terminology (CPT) covers CGM implementation and interpretation in your practice
· Use codes 95251 and 95249

6
Schedule a follow-up appointment or monitor remotely§

95251: Analysis, interpretation, and reporting of CGM data for a minimum of 72 hours of data collection
95249: Ambulatory CGM of interstitial tissue fluid via a subcutaneous sensor for a minimum of 72 hours; patient-provided equipment, sensor placement, hook-up, calibration of monitor, patient training and printout of recording5

Practice these steps with the LibreView* reports available to you.

Note: Abbott provides this information as a courtesy, it is subject to change and interpretation. The customer is ultimately responsible for determining the appropriate codes, coverage, and payment policies for individual patients. Abbott does not guarantee third party coverage or payment for our products or reimburse customers for claims that are denied by third party payors.

*The LibreView data management software is intended for use by both patients and healthcare professionals to assist people with diabetes and their healthcare professionals in the review, analysis and evaluation of historical glucose meter data to support effective diabetes management. The LibreView software is not intended to provide treatment decisions or to be used as a substitute for professional healthcare advice. Default range is 70-180 mg/dL. For adults with type 1 and type 2 diabetes who are not pregnant, not older, or at risk. §The user's device must have internet connectivity for glucose data to automatically upload to LibreView and to transfer to connected LibreLinkUp app users.

1. ADA. Diabetes Care (2023): https://doi.org/10.2337/dc23-S006. 2. ADCES (2020). Accessed August 2023. https://www.diabeteseducator.org/docs/default-source/practice/educator-tools/ cgm-playbooks/personal-cgm-playbook.pdf. 3. Bergenstal, R. M. ADA Clinical Compendia (2018): https://doi.org/10.2337/db20181-20. 4. Aleppo, G. Journal of Diabetes Science and Technology (2018): https://doi.org/10.1177/1932296818813581. 5. American Medical Association CPT. Professional Codebook (2023).

See last page for Important Safety Information.

Using the Ambulatory Glucose Profile report

Mirroring the recommendations of the International Consensus1, the Ambulatory Glucose Profile (AGP) report report reveals glucose variations that can help focus treatment1,2

See your patient's glucose metrics and time in ranges compared to goals Significance of Time in Range* (TIR): · Every 10% increase in TIR* =
~0.8% decrease in A1c3 · Each 5% increase in TIR* is clinically significant1
Review a 14-day glucose profile to see patterns, trends, and glycemic variability
Quick tips4: · FLAT is better than jagged · NARROW is better than broad · IN RANGE is better than outside of target range*

AGP Report
January 13, 2023 January 26, 2023 (14

GLUCOSE STATISTICS AND TARGETS

January 13, 2023 January 26, 2023 % Time CGM is Active

And

14 99.9%

`Glucose Ranges

Below

70Range 54

70-180

Above 180

Above 250

Targets of Readings
Gre thana70t%e(1r6h 48min)
Less than 4% (58min) Less than 1% (14min)
Less than 25% (6h)
Less than (1h 12min)

Average Glucose

Glucose Management Indicator (GMI)

as Glucose Variability
Defined percent coefficient of variation

target

173 7.6%

TIME IN RANGES Vary High

LibreView
20%

181-250

23%

Target Range

Low

Very Low

AMBULATORY GLUCOSE PROFILE (AGP)
350

Range

Identify specific glycemic events not visible in weekly averages.
Patient discussion tip:
Highlight glucose spikes or lows and ask the patient what may have caused the glycemic event

DAILY GLUCOSE PROFILES
Thursday

Sunday

Monday

Tuesday
1

Wednesday

Not actual patient data; for illustrative purposes only.

Make more informed decisions with individualized data not reflected by A1c1, with the AGP report.

*Default range is 70-180 mg/dL.

The LibreView data management software is intended for use by both patients and healthcare professionals to assist people with diabetes and their healthcare professionals in the review, analysis and evaluation of historical glucose meter data to support effective diabetes management. The LibreView software is not intended to provide treatment decisions or to be used as a substitute for professional healthcare advice.

1. Battelino, T. Diabetes Care (2019): https://doi.org/10.2337/dci19-0028. 2. ADA. Diabetes Care (2023): https://doi.org/10.2337/dc23-S006. 3. Vigersky, R. Diabetes Technology and Therapeutics (2019): https://doi.org/10.1089/dia.2018.0310. 4. Bergenstal, R. M. ADA Clinical Compendia (2018): https://doi.org/10.2337/db20181-20.

See last page for Important Safety Information.

Using the Glucose Pattern Insights report

The Glucose Pattern Insights (GPI) report provides a guided interpretation of your patient's CGM data to highlight important patterns

Compare glucose metrics with expert recommendations1,2

Quick tips:

· Teach patients to aim for more green and less red1

· Glucose Management Indicator (GMI) approximates a patient's A1c based on CGM data

LibreView
Generated: 10/06/2022 PAGE: 1 / 1

Personalize treatment with suggested clinical considerations
Quick tip: Discuss medication and lifestyle changes that prioritize addressing the most important glucose patterns
Identify when the most important glucose patterns occurred Significance of GPI: Glucose patterns give context to a patient's time spent out of range*

Highs
Device(s): FreeStyle Libre 3 1. Suggested considerations do not replace the opinion or advice of the healthcare provider.
Not actual patient data; for illustrative purposes only.

Use the GPI report to elevate patient care and interpret CGM data.

*Default range is 70-180 mg/dL.

1. Battelino, T. Diabetes Care (2019): https://doi.org/10.2337/dci19-0028. 2. ADA. Diabetes Care (2023): https://doi.org/10.2337/dc23-S006.

See last page for Important Safety Information.

Assessing additional reports

Using patient-specific data, LibreView* reports uncover hidden glucose patterns for a complete picture1

PAGE: 5 / 6 Generated: 10/06/2022

PAGE: 1 / 1 Generated: 10/06/2022

Demo Clinic PHONE: xxxxxxxxxx

SOURCES: FreeStyle Libre 2

Snapshot
September 23, 2022 - October 6, 2022 (14 Days)

Glucose

GMI 6.9% or 52 mmol/mol Carbs

AVERAGE GLUCOSE % above target
% in target
% below target

152 mg/dL
22 %

Average Glucose 350 mg/dL

76 %

180

Median

DAILY CARBS

503 grams/day

INSULIN
RAPID-ACTING INSULIN
Meal

units/day

LOW GLUCOSE EVENTS Average duration

1
420 Min

70 5th to 95th Percentiles

0 12am

6am

Low Glucose Events 100

80 70

40 12am

6am

12pm 12pm

6pm 6pm

12am

Correction
User Change
Manual
LONG-ACTING INSULIN

Total Daily Insulin

units/day units/day

Comments
· There were 2 ketone tests and the highest ketone result was 0.6 mmol/L. · Gaps found in the insulin data. 14 days 12am in this reporting period have no recorded

Sensor Usage

insulin events.

% Time Sensor is Active 100%

SNAPSHOT
An overview of your patient's average glucose and hypoglycemia events.

est Patient xx/xx/xxxx

SOURCES: FreeStyle Libre 2

Demo Clinic PHONE: xxxxxxxxxx

Daily Log
September 23, 2022 - October 6, 2022 (14 Days)

SAT Oct 1
Glucose mg/dL Carbs grams

12am 350

2am

180

4am

6am

8am

10am

12pm

2pm

212

4pm

6pm

8pm

10pm 12am

188

126

234

192

166

110g

179g

SUN Oct 2
Glucose mg/dL Carbs grams

12am 350

2am

4am

6am

8am

10am

12pm

2pm

4pm

243

6pm

8pm

10pm 12am

180

206

96*

162g

MON Oct 3
Glucose mg/dL Carbs grams

12am 350

2am

4am

6am

8am

10am

12pm

2pm

4pm

6pm

8pm

10pm 12am

180

*
70

115*

205

163

71g

144g

Weekly Summary
September 23, 2022 - October 6, 2022 (14 Days)

Glucose
Fri Sep 23
Sat Sep 24
Sun Sep 25
Mon Sep 26
Tue Sep 27

12am 350 mg/dL

180

0 350 mg/dL

12am

180

0 350 mg/dL

12am

180

0 350 mg/dL

12am

180

0 350 mg/dL

12am

180

6am

12pm

6pm

12am

226g

162g 179g 78g

293g

6am

12pm

6pm

107g

177g

12am

6am 66g

12pm 301g

6pm 179g

12am

6am

12pm

105g

362g

6pm

12am

200g

6am

12pm

6pm

12am

180g 144g

200g

Average Glucose

Total Carbs

Total Insulin

Low Events

124 938

mg/dL

grams

148 284

mg/dL

grams

175 546

mg/dL

grams

170 667

mg/dL

grams

138 595

DAILY LOG
Entries for each time the patient scanned/viewed their glucose, performed a blood glucose test, and entered carbohydrates, insulin, and exercise.

WEEKLY SUMMARY
Shows average glucose, scans/views, carbs, and insulin entered for a full week.

xx/xx/xxxx

Additional reports include:
Monthly Summary Monthly list of daily average glucose readings, glucose scans/ views per day, and low glucose events.

Mealtime Patterns
Highlights pre- and post-meal glucose levels throughout the day and daily averages for the 14-day wear period.

Daily Patterns
Shows glucose, carbohydrate, and insulin data over the "typical" day.

Not actual patient data; for illustrative purposes only.
Use different LibreView* reports to tailor your discussions to your patient's needs.

See last page for Important Safety Information.

Getting started is easy with LibreView*

Visit LibreView.com/auth/register and follow these 3 steps or scan the QR code:

1 Set up a LibreView* Practice account

2 Add Care Team members

3 Choose an option to connect with patients to share data

You can do this in 2 ways: Option 1: Share Practice ID Write your ID in the box to share with your patients
Customize your Practice ID with something memorable (e.g., consider using a phone number, name of practice,or the last name of a provider for your Practice ID)

Option 2: Invite new or existing patients
Add their email to your LibreView* Practice through the patient dashboard

Make the most of LibreView* data and reports today!

Call
Toll Free: (855) 450-3563 ext 3, Monday-Friday 9:00am - 8:00pm ET

LibreView Specialist Team
Email libreviewsupport@abbott.com

Book
1:1 session with the LibreView Specialist Team via their Team Booking Site - diabetescare.abbott/lvs

LibreView

Abbott the fullest

The user's device must have internet connectivity for glucose data to automatically upload to LibreView and to transfer to connected LibreLinkUp app users.

IMPORTANT SAFETY INFORMATION FreeStyle Libre 14 day, FreeStyle Libre 2 and FreeStyle Libre 3 systems: Failure to use FreeStyle Libre systems as instructed in labeling may result in missing a severe low or high glucose event and/ or making a treatment decision, resulting in injury. If glucose reading and alarms (if enabled) do not match symptoms or expectations, use a fingerstick value from a blood glucose meter for treatment decisions. Seek medical attention when appropriate or contact Abbott at 855-632-8658 or https://www.freestyle.abbott/us-en/safety-information.html for safety info.

The sensor housing, FreeStyle, Libre, and related brand marks are marks of Abbott. Other trademarks are property of their respective owners.

References

Veeva Vault Veeva Vault